Business Wire

JUNIPER-NETWORKS

23.2.2022 09:02:08 CET | Business Wire | Press release

Share
Juniper Networks 400G Platform Deployed by Sparkle for High-Speed International Connectivity and Enhanced User Experience

Juniper Networks, (NYSE: JNPR), a leader in secure, AI-driven networks, today announced that Sparkle , the first international service provider in Italy and among the top global operators, has deployed Juniper’s 400G solutions to meet increasing bandwidth demands reliably and cost-effectively. In addition, Juniper’s experience-first network solution supports Sparkle’s sustainability goals through power and space savings in its points of presence.

With its global Tier-1 IP Transit backbone “Seabone”, Sparkle is a Top 5 global IP player, providing high-speed and reliable Internet connectivity to ISPs and content providers worldwide. The service is delivered over an advanced proprietary network of over 600,000 km of fiber including major regional systems in Europe, the Mediterranean and the Americas, plus ownership of major international submarine cables. As Sparkle continues to innovate in the cloud era, Juniper Networks’ 400G solution helps Sparkle fulfill its mission to provide “bandwidth hungry” customers with customized solutions that deliver a superior end-user experience, competitive cost and top performance in the international telecommunications market.

News Highlights:

  • Juniper’s technology enables Sparkle to reduce space and power consumption in its core PoPs. 400G connections are also easier to manage with fewer overall ports. Juniper’s innovative silicon advancements reduce watts consumed per gigabit, allowing for high speed data transmissions at lower power levels.
  • Sparkle has deployed Juniper’s PTX Series Routers , high-performance, cloud-optimized platforms that enable smooth migration to 400G while delivering the bandwidth, flexibility and maturity that comes with Juniper’s latest generation silicon.
  • The PTX Series offers ultra-high port density, 400GbE support, flexible filtering and a reliable network operating system that has been powering generations of high-performance solutions.
  • 400G technology provides Sparkle with a new level of scale. 400G optical transceiver modules deliver a lower cost-per-bit by delivering the same bandwidth in less physical space. A 400G-capable network is a key step for Tier-1 providers like Sparkle, who are grappling with relentless traffic growth.

Supporting quotes:

“The 400G platform from Juniper will be a key tool in our ongoing challenge to match constantly growing traffic demands at very competitive price-per-port in the context of premium space and power costs, without sacrificing reliability and features. In addition, the better economy of scale and a denser configuration supports the high standard for eco-sustainable design and energy efficiency to which we work.”
- Enrico Bagnasco, Chief Technology Officer, Sparkle

“Juniper is pleased to support customers like Sparkle as they balance their sustainability journey with achieving their commercial goals and customer experience requirements. We share Sparkle’s vision of having a significantly positive impact on the environment and believe that innovation in sustainable technology is as important as reducing our environmental footprint.”
- Raj Yavatkar, Chief Technology Officer, Juniper Networks

Additional resources:

About Juniper Networks

Juniper Networks is dedicated to dramatically simplifying network operations and driving superior experiences for end users. Our solutions deliver industry-leading insight, automation, security and AI to drive real business results. We believe that powering connections will bring us closer together while empowering us all to solve the world’s greatest challenges of well-being, sustainability and equality. Additional information can be found at Juniper Networks (www.juniper.net ) or connect with Juniper on Twitter , LinkedIn and Facebook .

Juniper Networks, the Juniper Networks logo, Juniper, Junos, and other trademarks listed here are registered trademarks of Juniper Networks, Inc. and/or its affiliates in the United States and other countries. Other names may be trademarks of their respective owners.

category-serviceprovider

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release

If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids

Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release

Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use

DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release

-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release

Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye